Attitudes towards antidepressants among people living with inflammatory bowel disease: an online Australia-wide survey.

Mikocka-Walus, Antonina and Andrews, Jane M 2014, Attitudes towards antidepressants among people living with inflammatory bowel disease: an online Australia-wide survey., Journal of Crohns and Colitis, vol. 8, no. 4, pp. 296-303, doi: 10.1016/j.crohns.2013.09.002.

Attached Files
Name Description MIMEType Size Downloads

Title Attitudes towards antidepressants among people living with inflammatory bowel disease: an online Australia-wide survey.
Author(s) Mikocka-Walus, AntoninaORCID iD for Mikocka-Walus, Antonina orcid.org/0000-0003-4864-3956
Andrews, Jane M
Journal name Journal of Crohns and Colitis
Volume number 8
Issue number 4
Start page 296
End page 303
Total pages 8
Publisher Oxford University Press
Place of publication Oxford, Eng.
Publication date 2014-04
ISSN 1876-4479
Keyword(s) Antidepressants
Attitudes
Inflammatory bowel disease
Psychotherapy
Summary BACKGROUND AND AIMS: Little research has been conducted on antidepressants (ADs) in inflammatory bowel disease (IBD) despite their widespread use and evidence that they may improve immunoregulatory activity. The present study aimed 1) To explore the use and type(s) of ADs currently prescribed to people living with IBD and to collect evidence with respect to any observed effect of ADs on the course of IBD, and 2) To explore experiences and opinions regarding the effect of ADs on IBD course and attitudes towards future trials with ADs. METHODS: A cross-sectional exploratory Australia-wide online survey was conducted. Numerical results of the survey were summarised using descriptive statistics and open-ended questions using a simple content analysis. RESULTS: Overall, 98 IBD respondents participated in the survey, 50% with Crohn's disease, and 79% females. Sixty five (66%) participants reported current and 46 (47%) reported past AD use. Of the current AD users, 51 (79%) reported that the symptoms ADs were prescribed for improved. Psychological well-being improved in 87% of participants. The majority of respondents observed no change in IBD activity while on ADs, however, 16 (25%) believed that ADs improved their IBD. Most (84%) respondents would recommend ADs to other people living with IBD, and 81% reported willingness to participate in clinical trials with ADs. CONCLUSIONS: Future clinical trials on ADs are warranted and likely to be accepted by people living with IBD in need of mental health care; however, it is yet unknown whether ADs will have a specific impact on long-term IBD activity.
Language eng
DOI 10.1016/j.crohns.2013.09.002
Field of Research 110399 Clinical Sciences not elsewhere classified
170199 Psychology not elsewhere classified
Socio Economic Objective 920499 Public Health (excl. Specific Population Health) not elsewhere classified
HERDC Research category C1.1 Refereed article in a scholarly journal
ERA Research output type C Journal article
Copyright notice ©2014, Oxford University Press
Persistent URL http://hdl.handle.net/10536/DRO/DU:30088816

Document type: Journal Article
Collections: Faculty of Health
School of Psychology
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 13 times in TR Web of Science
Scopus Citation Count Cited 13 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 209 Abstract Views, 2 File Downloads  -  Detailed Statistics
Created: Mon, 14 Nov 2016, 13:07:30 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.